2-Aminophenoxazine-3-one and 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells

We examined intracellular pH (pHi) of ten cancer cell lines derived from different organs and two normal cell lines including human embryonic lung fibroblast cells (HEL) and human umbilical vein endothelial cells (HUVEC) in vitro, and found that pHi of most of these cancer cells was evidently higher (pH 7.5 to 7.7) than that of normal cells (7.32 and 7.44 for HEL and HUVEC, respectively) and that of primary leukemic cells and erythrocytes hitherto reported (≤7.2). Higher pHi in these cancer cells could be related to the Warburg effect in cancer cells with enhanced glycolytic metabolism. Since reversal of the Warburg effect may perturb intracellular homeostasis in cancer cells, we looked for compounds that cause extensive reduction of pHi, a major regulator of the glycolytic pathway and its associated metabolic pathway. We found that phenoxazine compounds, 2-aminophenoxazine-3-one (Phx-3) and 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one (Phx-1) caused a rapid and drastic dose-dependent decrease of pHi in ten different cancer cells within 30 min, though the extent of the decrease of pHi was significantly larger for Phx-3 (ΔpHi = 0.6 pH units or more for 100 µM Phx-3) than for Phx-1 (ΔpHi = 0.1 pH units or more for 100 µM Phx-1). This rapid and drastic decrease of pHi in a variety of cancer cells caused by Phx-3 and Phx-1 possibly perturbed their intracellular homeostasis, and extensively affected the subsequent cell death, because these phenoxazines exerted dose-dependent proapoptotic and cytotoxic effects on these cells during 72 h incubation, confirming a causal relationship between ΔpHi and cytotoxic effects due to Phx-3 and Phx-1. Phx-3 and Phx-1 also reduced pHi of normal cells including HEL and HUVEC, although they exerted less proapoptotic and cytotoxic effects on these cells than on cancer cells. Drugs such as Phx-3 and Phx-1 that reduce pHi and thereby induce cellular apoptosis might serve as benevolent anticancer drugs

Measuring epistemic curiosity in young children

Epistemic curiosity (EC) is the desire to obtain new knowledge capable of either producing positive experiences of intellectual interest (I-type) or of reducing undesirable conditions of informational deprivation (D-type). Although researchers acknowledge that there are individual differences in young children's epistemic curiosity, there are no existing measures to assess the I- and D-type constructs of EC in early childhood. The aim of this study was to develop and validate parent-report scales that reliably assessed early expressions of I- and D- type EC in young children. To develop the I/D-Young Children (I/D-YC) scales, 16 potential items were administered to 316 parents of children aged 3 to 8. These items were adaptations of an existing adult self-report measure of EC as well as newly developed items. Confirmatory factor analyses demonstrated that a 10-item 2-factor (5 I-type, 5 D-type) model had the best fit. Construct validity analyses and psychometric data indicated that our newly developed I/D-YC scales are valid and reliable measures of individual differences in early expressions of I- and D-type EC

At Odds with Curious Cats, Curious Robots Acquire Human-Like Intelligence

International audienceno abstrac